| Action Summary | The Board is amending 18VAC105-20-47 to add alpha-adrenergic agonists to the TPA formulary in the category of a Schedule VI topically administered medication. |
| Chapters Affected | Only affects this chapter. |
| Executive Branch Review | This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication. Exempt Citation: ยง 2.2-4002(14) |
| RIS Project | Yes [006523] |
| New Periodic Review | This action will not be used to conduct a new periodic review. |
| Name / Title: | Kelli Moss / Executive Director |
| Address: |
9960 Mayland Drive Suite 300 Henrico, VA 23233 |
| Email Address: | kelli.moss@dhp.virginia.gov |
| Phone: | (804)597-4077 FAX: (804)793-9145 TDD: ()- |